SCHEMBL7384136

SCHEMBL7384136

CCC(C(=O)O[C@@H]1CC(=O)NC1=O)c1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.44
KMT2A Q03164 3/20 0.44
ALDH1A1 P00352 1/20 0.43
GAA P10253 1/20 0.43
KDM4E B2RXH2 3/20 0.42
CHRM2 P08172 3/20 0.40
CYP19A1 P11511 2/20 0.40
CHRM5 P08912 2/20 0.40
CHRM1 P11229 2/20 0.40
CHRM3 P20309 2/20 0.40
HTR2C P28335 2/20 0.40
LMNA P02545 2/20 0.40
CYP17A1 P05093 1/20 0.40
POLB P06746 1/20 0.40
ADRA2C P18825 1/20 0.40
ADRA1A P35348 1/20 0.40
HRH1 P35367 1/20 0.40
BLM P54132 1/20 0.40
NFKB1 P19838 1/20 0.40
SLC22A1 O15245 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7381326 1.00 MEN1 (0.44) MEN1KMT2AALDH1A1GAAKDM4E
SCHEMBL7379863 1.00 MEN1 (0.44) MEN1KMT2AALDH1A1GAAKDM4E
SCHEMBL7385425 0.90 KCNQ2 (0.39) MEN1KMT2AALDH1A1KDM4ECHRM2
SCHEMBL7383686 0.88 BLM (0.39) MEN1KMT2AKDM4ECHRM2CHRM5
SCHEMBL7378937 0.88 KCNQ2 (0.40) MEN1KMT2AGAAKDM4ECHRM2
SCHEMBL7383592 0.88 CHRM2 (0.39) MEN1KMT2AALDH1A1KDM4ECHRM2
SCHEMBL7381276 0.86 GAA (0.42) KMT2AGAACYP19A1CYP17A1L3MBTL1
SCHEMBL7388484 0.85 HTT (0.41) MEN1KMT2AALDH1A1KDM4ECYP19A1
SCHEMBL7387023 0.85 KCNQ2 (0.45) KDM4EPOLBL3MBTL1
SCHEMBL7387268 0.84 GPBAR1 (0.39) MEN1KMT2AALDH1A1CHRM2CYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5281617-A Enzyme inhibitor CORTECH, INC. (US) 1994-01-25 US claimed
EP-1216230-A2 FUSED CYCLOHEPTANE AND FUSED AZACYCLOHEPTANE COMPOUNDS AND THEIR USE AS INTEGRIN RECEPTOR ANTAGONISTS Amgen Inc. (US) 2002-06-26 EP disclosed
WO-2001023357-A2 FUSED CYCLOHEPTANE AND FUSED AZACYCLOHEPTANE COMPOUNDS AND THEIR USE AS INTEGRIN RECEPTOR ANTAGONISTS AMGEN INC. (US) 2001-04-05 WO disclosed
US-5281617-A Enzyme inhibitor CORTECH, INC. (US) 1994-01-25 US disclosed